The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALIMERA SCIENCES INC COM 016259103 297 413,300 SH   SOLE   413,300 0 0
AMAZON COM INC COM 023135106 29,479 19,627 SH   SOLE   19,627 0 0
ANTARES PHARMA INC COM 036642106 5,224 1,920,524 SH   SOLE   1,920,524 0 0
APHRIA INC COM 03765K104 117 20,636 SH   SOLE   20,636 0 0
AURORA CANNABIS INC COM 05156X108 10,734 2,164,207 SH   SOLE   2,164,207 0 0
AVADEL PHARMACEUTICALS PLC SPONSORED ADR 05337M104 1,147 444,439 SH   SOLE   444,439 0 0
BIOSPECIFICS TECHNOLOGIES CO COM 090931106 4,463 73,649 SH   SOLE   73,649 0 0
CANOPY GROWTH CORP COM 138035100 34,688 1,291,201 SH   SOLE   1,291,201 0 0
CRONOS GROUP INC COM 22717L101 11,236 1,081,444 SH   SOLE   1,081,444 0 0
EAGLE PHARMACEUTICALS INC COM 269796108 17,154 425,755 SH   SOLE   425,755 0 0
ESTABLISHMENT LABS HLDGS INC COM G31249108 4,387 160,000 SH   SOLE   160,000 0 0
HORIZON PHARMA PLC SHS G4617B105 5,291 270,775 SH   SOLE   270,775 0 0
LIGAND PHARMACEUTICALS INC COM NEW 53220K504 1,819 13,401 SH   SOLE   13,401 0 0
MICROSOFT CORP COM 594918104 4,215 41,500 SH   SOLE   41,500 0 0
NOVELION THERAPEUTICS INC COM NEW 67001K202 265 315,979 SH   SOLE   315,979 0 0
OSMOTICA PHARMACEUTICALS PLC SHS G6S41R101 1,744 225,000 SH   SOLE   225,000 0 0
PETIQ INC COM CL A 71639T106 3,494 148,855 SH   SOLE   148,855 0 0